# Oxytocin Versus, Sublingual Misoprostol in the Secondary Prevention of Postpartum Hemorrhage After Vaginal Delivery

> **NCT05077540** · NA · UNKNOWN · sponsor: **Aswan University Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Labor Complication

## Interventions

- **DRUG:** oxytocin
- **DRUG:** misoprostol

## Key facts

- **NCT ID:** NCT05077540
- **Lead sponsor:** Aswan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2021-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05077540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05077540, "Oxytocin Versus, Sublingual Misoprostol in the Secondary Prevention of Postpartum Hemorrhage After Vaginal Delivery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05077540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*